GENETIC-POLYMORPHISM OF S-MEPHENYTOIN HYDROXYLATION

被引：254

作者：

WILKINSON, GR

GUENGERICH, FP

BRANCH, RA

机构：

[1] VANDERBILT UNIV,DEPT BIOCHEM,NASHVILLE,TN 37232

[2] VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37232

来源：

PHARMACOLOGY & THERAPEUTICS | 1989年 / 43卷 / 01期

关键词：

D O I：

10.1016/0163-7258(89)90047-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：53 / 76

页数：24

共 105 条

[1] MESANTOIN IN THE TREATMENT OF EPILEPSY - A STUDY OF ITS EFFECT ON THE LEUKOCYTE COUNT IN 79 CASES [J].

ABBOTT, JA ;

SCHWAB, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1954, 250 (05) :197-199

[2]

Anders MW, 1985, BIOACTIVATION FOREIG

[3]

ARNS PA, 1988, HEPATOLOGY, V8, P1277

[4]

ATIBA JO, 1988, CLIN PHARMACOL THER, V43, P136

[5] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].

AYESH, R ;

IDLE, JR ;

RITCHIE, JC ;

CROTHERS, MJ ;

HETZEL, MR .

NATURE, 1984, 312 (5990) :169-170

[6] GC AND GC-MS PROCEDURES FOR SIMULTANEOUS PHENOTYPING WITH DEXTROMETHORPHAN AND MEPHENYTOIN [J].

BAUMANN, P ;

JONZIERPEREY, M .

CLINICA CHIMICA ACTA, 1988, 171 (2-3) :211-222

[7] HUMAN ANTI-ENDOPLASMIC RETICULUM AUTOANTIBODIES APPEARING IN A DRUG-INDUCED HEPATITIS ARE DIRECTED AGAINST A HUMAN-LIVER CYTOCHROME-P-450 THAT HYDROXYLATES THE DRUG [J].

BEAUNE, P ;

DANSETTE, PM ;

MANSUY, D ;

KIFFEL, L ;

FINCK, M ;

AMAR, C ;

LEROUX, JP ;

HOMBERG, JC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (02) :551-555

[8]

BOOBIS AR, 1983, MOL PHARMACOL, V23, P474

[9] PHARMACOKINETICS OF (+)-HEXOBARBITONE, (-)-HEXOBARBITONE AND (+-]-HEXOBARBITONE IN MAN AFTER ORAL ADMINISTRATION [J].

BREIMER, DD ;

VANROSSU.JM .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (09) :762-764

[10]

BREIMER DD, 1978, CLIN PHARMACOL THER, V24, P208

← 1 2 3 4 5 6 7 8 9 10 →